Browsing by Author Keech, Anthony (Tony)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 124 < previous   next >
Issue DateTitleAuthor(s)Citation
2017Cognitive function in a randomized trial of evolocumabKeech, Anthony (Tony); Giugliano, Robert P; Honarpour, Narimon; Im, Kyungah; Kanevsky, Estella; Kurtz, C; Mach, Francois; Ott, Brian R.; Pedersen, Terje R; Robinson, Jennifer; Sabatine, Marc S.; Schneider, J; Sever, Peter; Wang, Huei; Wasserman, Scott M; Zavitz, Kenton H.; NH&MRC Clinical Trials CentreCognitive function in a randomized trial of evolocumab, New England Journal of Medicine, vol.377, 7, 2017,pp 633-643
2002Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusionAdams, Mark; Celermajer, David; Keech, Anthony (Tony); Kilian, Jens; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineCoronary collateralization: determinants of adequate distal vessel filling after arterial occlusion, Coronary Artery Disease, vol.13, 3,pp 155-159
2002Coronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsKeech, Anthony (Tony); Braunwald, Eugene; Craven, Timothy; Furberg, Curt D; Pfeffer, Marc A; Sacks, Frank M; Shepherd, James; Tonkin, Andrew M; School of Public Health: NH&MRC Clinical Trials CentreCoronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors, Circulation (Baltimore), vol.105,(12),2002,pp 1424-1428
2006Correction to the FIELD study reportBarter, Philip; Best, James; Keech, Anthony (Tony); Scott, R; Simes, Robert John; Taskinen, M; Central Clinical School: Medicine; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineCorrection to the FIELD study report, The Lancet, vol.368,(9545),2006,pp 1415-N/A
2009Cost-effectiveness Considerations of Cardiovascular TherapeuticsKeech, Anthony (Tony); Horowitz, John D.; School of Public Health: NH&MRC Clinical Trials CentreCost-effectiveness Considerations of Cardiovascular Therapeutics, Heart, Lung and Circulation, vol.18,(2),2009,pp 118-122
2017Cost-effectiveness of evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular diseaseKeech, Anthony (Tony); Fonarow, Gregg; Giugliano, Robert P; Lindgren, Peter; Pedersen, Terje R; Qian, Yi; Sabatine, Marc S.; Sever, Peter; Somaratne, Ransi; van Hout, Ben; Villa, Guillermo; NH&MRC Clinical Trials CentreCost-effectiveness of evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease, JAMA Cardiology, vol.2, 10, 2017,pp 1069-1078
2005Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial.Briffa, T; Eckermann, Simon; Freedman, Saul (Ben); Griffiths, Alison; Harris, Phillip; Keech, Anthony (Tony); Briffa, N. Kathryn; Donaldson, Lana; Heath, M. Rose; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; Concord Clinical School: ANZAC Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreCost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial., Medical Journal of Australia, vol.183,(9),2005,pp 450-455
2012A 'cure' for diabetes and its complicationsCraig, Maria; Donaghue, Kim; Keech, Anthony (Tony); O'Connell, Philip; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Millennium InstituteA 'cure' for diabetes and its complications in A Modern Epidemic: Expert Perspectives on Obesity and Diabetes, Sydney University Press, 2012, pp. 401-420
2017Delayed versus Immediate Cord Clamping in Preterm InfantsAskie, Lisa; Brown, Rebecca; Evans, Nicholas; Finlayson, Sarah; Fogarty, Michael; Gebski, Val; Ghadge, Alpana; Hague, Wendy; Isaacs, David; Jeffery, Michele; Keech, Anthony (Tony); Kirby, Adrienne; Kluckow, Martin; Liley, Helen; Morris, Jonathan; Osborn, David; Popat, Himanshu; Robledo, Kristy; Sebastian, Lucille; Simes, Robert John; Tarnow-Mordi, William; Aagaard, K; Abdel-Latif, Mohamed E; Ariff, Shabina; Belfort, M; Chen, Y; Colditz, Paul B.; et al, Various; Pammi, M; Reynolds, G; Sheikh, L; NH&MRC Clinical Trials Centre; School of Public Health: Public Health; Central Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Childrens Hospital Westmead: Paediatrics & Child Health; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; Central Clinical School: Obstetrics & Gynaecology; Central Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreDelayed versus Immediate Cord Clamping in Preterm Infants, New England Journal of Medicine, vol.377, 25, 2017,pp 2445-2455
2017Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the FOURIER trialKeech, Anthony (Tony); Giugliano, Robert P; Honarpour, Narimon; Kurtz, C; Mach, Francois; Ott, Brian R.; Pedersen, T; Sabatine, Marc S.; Schneider, J; Sever, Peter; Wang, Huei; Wasserman, Scott M; Zavitz, Kenton H.; NH&MRC Clinical Trials CentreDesign and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the FOURIER trial, Clinical Cardiology, vol.40, 2, 2017,pp 59-65
2003Determining the sample size in a clinical trial [in reply]Gebski, Val; Keech, Anthony (Tony); Kirby, Adrienne; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreDetermining the sample size in a clinical trial [in reply], Medical Journal of Australia, vol.178,(7),2003,pp 358-358
2002Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart diseaseKeech, Anthony (Tony); MacMahon, Stephen; Neal, Bruce; Ohkubo, Takayoshi; Tonkin, Andrew; Wilcken, David E.; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International Health; Medicine; Medicine Faculty OfficeDose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease, European Heart Journal, vol.23,(19),2002,pp 1509-1515
2009Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trialKeech, Anthony (Tony); Li, Li Ping; Rajamani, Kushwin; Voysey, Merryn; Baker, John R.; Best, James; Coleman, Peter G.; D'Emden, Michael C.; FIELD study investigators, Fenofibrate Intervention and Event Lowering in Diabetes; Laakso, Markku; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreEffect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial, The Lancet, vol.373, 9677, 2009,pp 1780-1788
2007Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialKeech, Anthony (Tony); Merrifield, Alistair; Mitchell, Ronald (Paul); Moffitt, Mireille; O'Connell, Rachel; Simes, Robert John; Tse, D; Williamson, E; Crimet, D. C.; Davis, T. M. E.; D'Emden, MC; Laatikainen, LT; O'Day, J; Summanen, PA; Taskinen, M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Clinical Ophthal & Eye Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial, The Lancet, vol.370,(9600),2007,pp 1687-1697
2005Effect of pravastatin in people with chronic kidney disease and diabetes mellitus.Keech, Anthony (Tony); Simes, Robert John; Craven, Timothy; Curhan, Gary; Furberg, Curt D; Isles, Chris; Packard, Chris; Pfeffer, Marc A; Sacks, Frank M; Shepherd, Jim; Tonelli, Marcello; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of pravastatin in people with chronic kidney disease and diabetes mellitus., Hypertension 2005, vol.46,(4),2005,pp 900-901
2005Effect of pravastatin in people with diabetes and chronic kidney disease.Keech, Anthony (Tony); Simes, Robert John; et, al; Furberg, C; Isles, Chris; Packard, Chris; Pfeffer, M; Sacks, Frank; Shepherd, Jim; Tonelli, Marcello; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of pravastatin in people with diabetes and chronic kidney disease., Journal of the American Society of Nephrology, vol.16,(12),2005,pp 3748-3754
2012Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyForder, Peta; Keech, Anthony (Tony); Simes, Robert John; Voysey, Merryn; Glasziou, Paul; Hamer, Andrew; Hunt, David; Kesaniemi, Y. Antero; Mahar, Leo; Mann, Stewart; Tonkin, Andrew; Waites, Jonathon H; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, American Heart Journal, vol.163, 3, 2012,pp 508-514
2010Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyDonoghoe, Mark; Gebski, Val; Keech, Anthony (Tony); O'Connell, Rachel; Simes, Robert John; Ting, R; Best, J; Davis, T. M. E.; Drury, P.L.; Glasziou, Paul .P.; Jenkins, Alicia J.; Kesaniemi, Y. Antero; Scott, R; Sullivan, D; Whiting, M. J.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study, Diabetologia: clinical and experimental diabetes and metabolism, vol.54, 2,pp 280-290
2009The effects of fenofibrate treatment on cardiovascular disease risk in 9795 people with type 2 diabetes and various components of the metabolic syndrome: the FIELD study.Fulcher, Greg; Keech, Anthony (Tony); Pardy, Christopher; Tse, D; D'Emden, Michael C.; Ehnholm, Christian; FIELD study investigators, Fenofibrate Intervention and Event Lowering in Diabetes; O'Brien, Richard; Scott, Russell; Taskinen, M.; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe effects of fenofibrate treatment on cardiovascular disease risk in 9795 people with type 2 diabetes and various components of the metabolic syndrome: the FIELD study., Diabetes Care, vol.32,(3),2009,pp 493-498
2005Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.Barter, Philip; Best, James; Davis, Tracey; Forder, Peta; Glasziou, Paul; Keech, Anthony (Tony); Pillai, Avineshwaran; Scott, R; Simes, Robert John; Sullivan, David; Taskinen, M; Drury, P; et, al; Kesaniemi, Y. Antero; Central Clinical School: Medicine; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Molecular Bioscience; Central Clinical School: MedicineEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial., The Lancet, vol.366,(9500),2005,pp 1849-1861